These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28965551)

  • 21. Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?
    Homburg R; Meltcer S; Rabinson J; Zohav E; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1311-3. PubMed ID: 18384783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian stimulation in ART - Unwinding pressing issues.
    Zech NH; Zech M; Baldauf S; Comploj G; Murtinger M; Spitzer D; Hradecký L; Ajayi R; Schuff M; Zech H
    Minerva Ginecol; 2015 Apr; 67(2):127-47. PubMed ID: 25668422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F; Rodríguez DB; Buxaderas R; Tur R; Mancini F; Coroleu B
    Fertil Steril; 2011 Jun; 95(7):2432.e17-9. PubMed ID: 21513932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose human chorionic gonadotropin alone can complete follicle maturity: successful application to modified natural cycle in vitro fertilization.
    Paulson RJ; Chung K; Quaas AM; Mucowski SJ; Jabara SI; Bendikson KA
    Fertil Steril; 2016 May; 105(5):1228-1231. PubMed ID: 26852420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
    Casper RF
    Fertil Steril; 2015 Apr; 103(4):867-9. PubMed ID: 25712575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro fertilization (IVF): why doing it in unstimulated cycles?].
    Basille C; Fay S; Hesters L; Frydman N; Frydman R
    Gynecol Obstet Fertil; 2007 Sep; 35(9):877-80. PubMed ID: 17827049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the use of gonadotropin-releasing hormone antagonists in natural IVF cycles for poor responder patients cause more harm than benefit?
    Aksoy S; Yakin K; Seyhan A; Oktem O; Alatas C; Ata B; Urman B
    Hum Fertil (Camb); 2016 Jun; 19(2):97-101. PubMed ID: 26986742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes for various causes of infertility with natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes.
    Xu Y; Li J; Zhou G; Guo J
    Fertil Steril; 2010 Jul; 94(2):777-80. PubMed ID: 19909949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild stimulation for in vitro fertilization.
    Nargund G; Datta AK; Fauser BCJM
    Fertil Steril; 2017 Oct; 108(4):558-567. PubMed ID: 28965549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CHALLENGING THE OPTIMAL NUMBER OF RETRIEVED OOCYTES AND ITS IMPACT ON PREGNANCY AND LIVE BIRTH RATES IN IVF/ICSI CYCLES].
    Blais I; Lahav-Baratz S; Koifman M; Wiener-Megnazi Z; Auslender R; Dirnfeld M
    Harefuah; 2015 Jun; 154(6):350-5, 406. PubMed ID: 26281076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer.
    Teramoto S; Osada H; Sato Y; Shozu M
    Fertil Steril; 2016 Jul; 106(1):113-118. PubMed ID: 27041027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction: Contemporary approaches to alternative ovarian stimulation strategies for in vitro fertilization.
    Paulson RJ
    Fertil Steril; 2017 Oct; 108(4):555-557. PubMed ID: 28911928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.